HK Stock MarketDetailed Quotes
02480 LUZHU BIOTECH-B
- 22.800
- -0.050-0.22%
Trading Aug 26 10:16 CST
4.58BMarket Cap-14941P/E (TTM)
22.800High22.800Low1.40KVolume22.800Open22.850Pre Close31.92KTurnover0.00%Turnover RatioLossP/E (Static)201.01MShares41.00052wk High4.43P/B4.58BFloat Cap17.00052wk Low--Dividend TTM201.01MShs Float42.000Historical High--Dividend LFY0.00%Amplitude16.140Historical Low22.800Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
LUZHU BIOTECH-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|
| Operating income | ||||||||
| Operating expenses | ||||||||
| Gross profit | ||||||||
| Administrative expenses | -9.03%-44.96M | -1.38%-87.01M | ---41.24M | -42.53%-85.83M | 19.57%-18.39M | -1,731.97%-60.22M | ---22.86M | ---3.29M |
| Research and development expenses | -142.41%-80.38M | -88.88%-172.69M | ---33.16M | -112.70%-91.43M | -120.55%-21.75M | -174.39%-42.98M | ---9.86M | ---15.67M |
| Revaluation surplus | ---- | ---- | ---- | -25.05%-551.55M | 99.85%-132K | -167.23%-441.08M | ---88.22M | ---165.06M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | -25.05%-551.55M | 99.85%-132K | -167.23%-441.08M | ---88.22M | ---165.06M |
| Special items of operating profit | 445.69%15.8M | 157.60%11.19M | ---4.57M | -21.35%4.34M | 18.71%2.68M | -44.91%5.52M | --2.26M | --10.03M |
| Operating profit | -38.72%-109.54M | 65.70%-248.51M | -78.97M | -34.47%-724.46M | 68.33%-37.58M | -209.66%-538.75M | -118.68M | -173.98M |
| Financing cost | -3.11%-398K | -16.90%-844K | ---386K | -19.73%-722K | -6.21%-154K | -813.64%-603K | ---145K | ---66K |
| Adjustment items of earning before tax | ---- | ---- | ---- | ---- | ---6.56M | ---- | ---- | ---- |
| Earning before tax | -38.54%-109.94M | 65.62%-249.35M | -79.35M | -34.45%-725.18M | 62.72%-44.3M | -209.89%-539.36M | -118.82M | -174.05M |
| After-tax profit from continuing operations | -38.54%-109.94M | 65.62%-249.35M | -79.35M | -34.45%-725.18M | 62.72%-44.3M | -209.89%-539.36M | -118.82M | -174.05M |
| Earning after tax | -38.54%-109.94M | 65.62%-249.35M | -79.35M | -34.45%-725.18M | 62.72%-44.3M | -209.89%-539.36M | -118.82M | -174.05M |
| Profit attributable to shareholders | -38.54%-109.94M | 65.62%-249.35M | -79.35M | -34.45%-725.18M | 62.72%-44.3M | -209.89%-539.36M | -118.82M | -174.05M |
| Basic earnings per share | -31.71%-0.54 | 74.90%-1.25 | -0.41 | 16.16%-4.98 | 62.88%-0.49 | -206.19%-5.94 | -1.32 | -1.94 |
| Diluted earnings per share | -31.71%-0.54 | 74.90%-1.25 | -0.41 | 16.16%-4.98 | 62.88%-0.49 | -206.19%-5.94 | -1.32 | -1.94 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg